QSAR As a Random Event: a Case of NOAEL

Overview

Journal Environ Sci Pollut Res Int

Publisher Springer

Specialties Environmental Health
Toxicology

Date 2014 Dec 19

PMID 25520208

Citations 12

Authors

Alla P Toropova

Andrey A Toropov

Jovana B Veselinovic

Aleksandar M Veselinovic

Affiliations

Soon will be listed here.

Abstract

Quantitative structure-activity relationships (QSAR) for no observed adverse effect levels (NOAEL, mmol/kg/day, in logarithmic units) are suggested. Simplified molecular input line entry systems (SMILES) were used for molecular structure representation. Monte Carlo method was used for one-variable models building up for three different splits into the "visible" training set and "invisible" validation. The statistical quality of the models for three random splits are the following: split 1 n = 180, r (2) = 0.718, q (2) = 0.712, s = 0.403, F = 454 (training set); n = 17, r (2) = 0.544, s = 0.367 (calibration set); n = 21, r (2) = 0.61, s = 0.44, r m (2) = 0.61 (validation set); split 2 n = 169, r (2) = 0.711, q (2) = 0.705, s = 0.409, F = 411 (training set); n = 27, r (2) = 0.512, s = 0.461 (calibration set); n = 22, r (2) = 0.669, s = 0.360, r m (2) = 0.63 (validation set); split 3 n = 172, r (2) = 0.679, q (2) = 0.672, s = 0.420, F = 360 (training set); n = 19, r (2) = 0.617, s = 0.582 (calibration set); n = 21, r (2) = 0.627, s = 0.367, r m (2) = 0.54 (validation set). All models are built according to OCED principles.

Citing Articles

Reproducibility of organ-level effects in repeat dose animal studies.

Paul Friedman K, Foster M, Pham L, Feshuk M, Watford S, Wambaugh J Comput Toxicol. 2023; 28:1-17.

PMID: 37990691 PMC: 10659077. DOI: 10.1016/j.comtox.2023.100287.

Cheminformatics and Machine Learning Approaches to Assess Aquatic Toxicity Profiles of Fullerene Derivatives.

Fjodorova N, Novic M, Venko K, Rasulev B, Turker Sacan M, Tugcu G Int J Mol Sci. 2023; 24(18).

PMID: 37762462 PMC: 10531479. DOI: 10.3390/ijms241814160.

How fullerene derivatives (FDs) act on therapeutically important targets associated with diabetic diseases.

Fjodorova N, Novic M, Venko K, Drgan V, Rasulev B, Turker Sacan M Comput Struct Biotechnol J. 2022; 20:913-924.

PMID: 35242284 PMC: 8861571. DOI: 10.1016/j.csbj.2022.02.006.

In Silico Models for Repeated-Dose Toxicity (RDT): Prediction of the No Observed Adverse Effect Level (NOAEL) and Lowest Observed Adverse Effect Level (LOAEL) for Drugs.

Pizzo F, Gadaleta D, Benfenati E Methods Mol Biol. 2022; 2425:241-258.

PMID: 35188636 DOI: 10.1007/978-1-0716-1960-5_11.

Structure-based QSAR Models to Predict Repeat Dose Toxicity Points of Departure.

Pradeep P, Paul Friedman K, Judson R Comput Toxicol. 2021; 16(November 2020).

PMID: 34017928 PMC: 8128699. DOI: 10.1016/j.comtox.2020.100139.

References

Toropova A, Toropov A, Benfenati E, Gini G, Leszczynska D, Leszczynski J . CORAL: quantitative structure-activity relationship models for estimating toxicity of organic compounds in rats. J Comput Chem. 2011; 32(12):2727-33. DOI: 10.1002/jcc.21848. View

Garro Martinez J, Duchowicz P, Estrada M, Zamarbide G, Castro E . QSAR study and molecular design of open-chain enaminones as anticonvulsant agents. Int J Mol Sci. 2012; 12(12):9354-68. PMC: 3257134. DOI: 10.3390/ijms12129354. View

Park Y, Cho M . A New Way in Deciding NOAEL Based on the Findings from GLP-Toxicity Test. Toxicol Res. 2013; 27(3):133-5. PMC: 3834376. DOI: 10.5487/TR.2011.27.3.133. View

Toropov A, Toropova A, Puzyn T, Benfenati E, Gini G, Leszczynska D . QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells. Chemosphere. 2013; 92(1):31-7. DOI: 10.1016/j.chemosphere.2013.03.012. View

Mazzatorta P, Estevez M, Coulet M, Schilter B . Modeling oral rat chronic toxicity. J Chem Inf Model. 2008; 48(10):1949-54. DOI: 10.1021/ci8001974. View

Zhu H, Ye L, Richard A, Golbraikh A, Wright F, Rusyn I . A novel two-step hierarchical quantitative structure-activity relationship modeling work flow for predicting acute toxicity of chemicals in rodents. Environ Health Perspect. 2009; 117(8):1257-64. PMC: 2721870. DOI: 10.1289/ehp.0800471. View

Garcia J, Duchowicz P, Rozas M, Caram J, Mirifico M, Fernandez F . A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases. J Mol Graph Model. 2011; 31:10-9. DOI: 10.1016/j.jmgm.2011.07.007. View

Nesmerak K, Toropov A, Toropova A, Kohoutova P, Waisser K . SMILES-based quantitative structure-property relationships for half-wave potential of N-benzylsalicylthioamides. Eur J Med Chem. 2013; 67:111-4. DOI: 10.1016/j.ejmech.2013.05.031. View

Dobchev D, Tulp I, Karelson G, Tamm T, Tamm K, Karelson M . Subchronic Oral and Inhalation Toxicities: a Challenging Attempt for Modeling and Prediction. Mol Inform. 2016; 32(9-10):793-801. DOI: 10.1002/minf.201300033. View

10.

Lewis R, Billington R, Debryune E, Gamer A, Lang B, Carpanini F . Recognition of adverse and nonadverse effects in toxicity studies. Toxicol Pathol. 2002; 30(1):66-74. DOI: 10.1080/01926230252824725. View

11.

Rupp B, Appel K, Gundert-Remy U . Chronic oral LOAEL prediction by using a commercially available computational QSAR tool. Arch Toxicol. 2010; 84(9):681-8. DOI: 10.1007/s00204-010-0532-x. View

12.

Parasuraman S . Toxicological screening. J Pharmacol Pharmacother. 2011; 2(2):74-9. PMC: 3127354. DOI: 10.4103/0976-500X.81895. View

13.

Contrera J, Matthews E, Kruhlak N, Benz R . Estimating the safe starting dose in phase I clinical trials and no observed effect level based on QSAR modeling of the human maximum recommended daily dose. Regul Toxicol Pharmacol. 2004; 40(3):185-206. DOI: 10.1016/j.yrtph.2004.08.004. View

14.

Toropova A, Toropov A . CORAL software: prediction of carcinogenicity of drugs by means of the Monte Carlo method. Eur J Pharm Sci. 2014; 52:21-5. DOI: 10.1016/j.ejps.2013.10.005. View

15.

Roy K, Mitra I, Kar S, Ojha P, Das R, Kabir H . Comparative studies on some metrics for external validation of QSPR models. J Chem Inf Model. 2011; 52(2):396-408. DOI: 10.1021/ci200520g. View

16.

Toropova A, Toropov A . Optimal descriptor as a translator of eclectic information into the prediction of membrane damage by means of various TiO(2) nanoparticles. Chemosphere. 2013; 93(10):2650-5. DOI: 10.1016/j.chemosphere.2013.09.089. View

17.

Gajewska M, Worth A, Urani C, Briesen H, Schramm K . Application of physiologically-based toxicokinetic modelling in oral-to-dermal extrapolation of threshold doses of cosmetic ingredients. Toxicol Lett. 2014; 227(3):189-202. DOI: 10.1016/j.toxlet.2014.03.013. View

18.

Veselinovic A, Milosavljevic J, Toropov A, Nikolic G . SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL. Eur J Pharm Sci. 2013; 48(3):532-41. DOI: 10.1016/j.ejps.2012.12.021. View

19.

Afantitis A, Melagraki G, Koutentis P, Sarimveis H, Kollias G . Ligand-based virtual screening procedure for the prediction and the identification of novel β-amyloid aggregation inhibitors using Kohonen maps and Counterpropagation Artificial Neural Networks. Eur J Med Chem. 2010; 46(2):497-508. DOI: 10.1016/j.ejmech.2010.11.029. View

20.

Toropov A, Toropova A, Benfenati E . QSPR modeling bioconcentration factor (BCF) by balance of correlations. Eur J Med Chem. 2009; 44(6):2544-51. DOI: 10.1016/j.ejmech.2009.01.023. View